全部

1·The use of the anthracycline doxorubicin is restricted by its cardiac toxicity.

使用蒽环类药物阿霉素是限制其心脏毒性。

2·The adsorption behavior of chemotherapy doxorubicin on magnetic nanoparticles was studied.

研究化疗药物阿霉素在磁性纳米微球表面的吸脱附行为。

3·Objective To find an effective protective method for preventing doxorubicin vascular leakage.

目的寻找多柔比星（阿霉素）血管外渗有效的防护方法。

4·Objective To study the effect of doxorubicin on calcium channels of OS-732 and R-OS-732 cells.

目的探讨阿霉素对骨肉瘤(OS 732)及其耐药细胞(R OS 732)钙离子通道的影响。

5·Adriamycin (also called doxorubicin) is the main chemotherapy drug used for primary liver cancer.

阿霉素是主要原发性肝癌化疗治疗药物之一。

6·Objective To probe the nursing method, abate the local side reaction of chemotherapy with doxorubicin.

目的探讨减轻蒽环类化疗药物在治疗过程中所致局部不良反应的护理方法。

7·In this study, the researchers attached two drugs - TRAIL and doxorubicin (dox) - onto graphene strips.

在这项研究中，研究人员把两种药物——抗癌蛋白trail和阿霉素(强力霉素)——连接到石墨烯带。

8·Conclusion: Doxorubicin phospholipid nanoparticle is able to become a new drug targeting carrier system.

结论：肝癌特异性多柔比星免疫磷脂纳米粒，有可能成为一种新的药物靶向载体系统。

9·OBJECTIVE To compare the antitumor activity between stealth liposomal doxorubicin and regular liposomal doxorubicin.

目的比较阿霉素隐形脂质体与普通脂质体的抗肿瘤活性。

10·This translates into enhanced therapeutic efficacy for drugs like doxorubicin that have intracellular site of action.

继而又转化成提高阿霉素这类作用于细胞内位点药物的治疗效果。

阿霉素

1·Depending on caspase activation, methadone overcomes doxorubicin resistance, multidrug resistance, and apoptosis resistance in leukemia cells through activation of mitochondria.

依赖于半胱氨酸蛋白酶的激活，美沙酮通过激活线粒体克服了白血病细胞中的阿霉素耐药、多药耐药、和凋亡抑制。

2·Conclusion Magnetic doxorubicin stealth liposome as a new anti-tumor drug carrier may have a favorable clinical prospect.

结论磁性阿霉素隐形脂质体作为一种新型抗肿瘤药物显示了良好的应用前景。

3·The use of the anthracycline doxorubicin is restricted by its cardiac toxicity.

使用蒽环类药物阿霉素是限制其心脏毒性。

4·Objective To study the effect of magnetic doxorubicin stealth liposome on human gastric cancer xenografts in nude mice.

目的探讨磁性阿霉素隐形脂质体靶向治疗裸鼠移植性人胃癌的疗效。

5·Conclusion: Magnetic doxorubicin stealth liposome, regarding as a new kind carrier of anti-tumor drug, indicated a favorable foreground.

结论：磁性阿霉素隐形脂质体作为一种新型抗肿瘤药物显示了良好的应用前景。